The effect of Cop 1, a synthetic polypeptide, on chronic relapsing experimental allergic encephalomyelitis in guinea pigs
- 1 July 1979
- journal article
- research article
- Published by Elsevier BV in Journal of the Neurological Sciences
- Vol. 42 (2), 267-274
- https://doi.org/10.1016/0022-510x(79)90058-3
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Suppression of Chronic Allergic Encephalomyelitis: Relevance to Multiple SclerosisScience, 1978
- Effect of a synthetic polypeptide (Cop 1) on patients with multiple sclerosis and with acute disseminated encephalomyelitisJournal of the Neurological Sciences, 1977
- Failure of basic protein therapy for multiple sclerosisZeitschrift für Neurologie, 1977
- Immune protection against experimental autoimmune encephalomyelitis: Optimal conditions and analysis of mechanismCellular Immunology, 1974
- Myelin Basic Protein Administration in Multiple SclerosisArchives of Neurology, 1973
- Failure of antilymphocytic globulin therapy in chronic progressive multiple sclerosisNeurology, 1973
- Suppression by several synthetic polypeptides of experimental allergic encephalomyelitis induced in guinea pigs and rabbits with bovine and human basic encephalitogenEuropean Journal of Immunology, 1973
- Multiple Sclerosis Unaffected by Azathioprine in Pilot StudyArchives of Neurology, 1973
- Suppression of experimental allergic encephalomyelitis by a synthetic polypeptideEuropean Journal of Immunology, 1971
- CYCLOPHOSPHAMIDE IN MULTIPLE SCLEROSISThe Lancet, 1969